Invictus MD Strategies (Invictus MD Strategies) Research & Development : $0.00 Mil (TTM As of Oct. 2019)

View and export this data going back to 2015. Start your Free Trial

What is Invictus MD Strategies Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Invictus MD Strategies's Research & Development for the three months ended in Oct. 2019 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Oct. 2019 was $0.00 Mil.

Invictus MD Strategies Research & Development Historical Data

The historical data trend for Invictus MD Strategies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invictus MD Strategies Research & Development Chart

Invictus MD Strategies Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Research & Development

0.01

Invictus MD Strategies Quarterly Data
	Jan15	Apr15	Jul15	Oct15	Jan16	Apr16	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19
Research & Development	Get a 7-Day Free Trial															-	-	-	-	-

Invictus MD Strategies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Oct. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Invictus MD Strategies (OTCPK:IVITF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Invictus MD Strategies Research & Development Related Terms

Thank you for viewing the detailed overview of Invictus MD Strategies's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Invictus MD Strategies (Invictus MD Strategies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Invictus MD Strategies Corp (OTCPK:IVITF) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

595 Burrard Street, 16th floor, Vancouver, BC, CAN, V7X 1J1

Website

http://www.invictus-md.com

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.